Indian Generic Drug Market May Grow Fivefold In 10 To 15 Years

India is now trying to focus on drug development and discovery for urban diseases and diseases that do not have a proper treatment protocol.

In the next 10 to 15 years, India’s pharmaceutical sector can grow five times and in the growth process, innovation should act as a catalyst, said a senior official.

"While India has achieved a good position in generic drugs and is self reliant but India has the potential to become a drug discovery destination. The generic drug market may grow another five times over a period of time - another 10 or 15 years and drug innovation should act as a catalyst to that growth," V.K. Subburaj, secretary in department of pharmaceuticals of the chemicals and fertilizers ministry.

Indian Pharmaceutical Cuts Down Supply Of Razumab Following Adverse Eye Reactions
The injectable drug produced by Intas Bio-pharmaceuticals that was used to treat macular degeneration, caused inflammation of inner coats of the eye.

Attending the National Institute of Pharmaceutical Education and Research - Kolkata's (NIPER) fourth convocation at the CSIR-Indian Institute of Chemical Biology campus, Subburaj, who is also the chairman of NIPER's steering committee, said India is now trying to focus on drug development and discovery for urban diseases and diseases that do not have a proper treatment protocol.

"Some companies are developing drugs for Alzheimer's, some for arthritis. Indian institutes, especially the NIPERs should do research and innovation in this area," he said.

He said another thrust area for the pharmaceutical sector should be on improving the quality of existing units.

Indian Pharmaceutical Company Opens a R&D Center for Inhalation Products in the US
Lupin’s center at Florida will focus on developing inhalation products for the treatment of asthma, allergic rhinitis and other lung diseases.

"There are 12, 000 pharma units in the country. Only 14 to 15 percent are complying with good manufacturing practices. Remaining 85 percent are very small and located in various places.

"So they should concentrate on upgrading themselves to the WHO standards and that only will give more confidence to other countries. Today India means high quality generic drugs," he said, adding the Indian government wants to make medical devices indigenously.

Indian Pharmaceutical Company Recalls Anti-seizure and Hypertension Drugs from US Market
Hyderabad-based Dr Reddy’s Laboratories recalled the drugs as the tablets failed dissolution test and some are close to expiry date.

Quizzed on Baba Ramdev's AIDS cure, Subburaj declined to comment but said every discipline of complementary medicine has some benefits.

Union Minister of State for Health and AYUSH Shripad Naik had recently said the union health ministry could use Baba Ramdev's reported cure to HIV/AIDS if it is clinically cleared.

Indian Pharmaceutical Industry can Gain from Africa's Growing Drug Market: Report
The worldwide demand for cost-effective generic drugs is leading India to rise as a hub of generic drug manufacturing, reveals a global consultancy.

Source-IANS